Trust Investment Advisors cut its stake in Cigna Corporation (NYSE:CI) by 5.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,780 shares of the health services provider’s stock after selling 300 shares during the period. Trust Investment Advisors’ holdings in Cigna Corporation were worth $894,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in Cigna Corporation by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after buying an additional 1,184,632 shares during the period. FMR LLC lifted its stake in Cigna Corporation by 6.7% in the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after buying an additional 432,978 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in Cigna Corporation by 4,082.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 438,231 shares of the health services provider’s stock valued at $73,355,000 after buying an additional 427,754 shares during the period. Vanguard Group Inc. lifted its stake in Cigna Corporation by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after buying an additional 424,469 shares during the period. Finally, American Century Companies Inc. lifted its stake in Cigna Corporation by 56.9% in the second quarter. American Century Companies Inc. now owns 1,140,341 shares of the health services provider’s stock valued at $190,882,000 after buying an additional 413,759 shares during the period. Institutional investors and hedge funds own 89.69% of the company’s stock.
In other Cigna Corporation news, Director William D. Zollars sold 1,232 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Mary T. Hoeltzel sold 575 shares of the company’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $197.03, for a total value of $113,292.25. Following the completion of the transaction, the chief accounting officer now owns 2,499 shares of the company’s stock, valued at approximately $492,377.97. The disclosure for this sale can be found here. Insiders sold a total of 4,290 shares of company stock valued at $792,090 in the last 90 days. Corporate insiders own 1.30% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://transcriptdaily.com/2017/11/14/trust-investment-advisors-has-894000-position-in-cigna-corporation-ci.html.
CI has been the topic of a number of research reports. Morgan Stanley upped their target price on Cigna Corporation from $184.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, August 7th. Deutsche Bank AG upped their target price on Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, August 7th. BidaskClub raised Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 18th. Jefferies Group LLC upped their target price on Cigna Corporation from $221.00 to $231.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Finally, Credit Suisse Group reaffirmed a “buy” rating and set a $196.00 target price on shares of Cigna Corporation in a research report on Friday, August 4th. Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Cigna Corporation has an average rating of “Buy” and an average price target of $201.50.
Shares of Cigna Corporation (NYSE CI) traded down $1.60 during trading hours on Tuesday, reaching $196.02. The company’s stock had a trading volume of 325,357 shares, compared to its average volume of 1,361,937. The company has a market cap of $48,811.91, a P/E ratio of 19.07, a PEG ratio of 1.51 and a beta of 0.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39. Cigna Corporation has a 52-week low of $131.03 and a 52-week high of $206.45.
Cigna Corporation (NYSE:CI) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The firm had revenue of $10.38 billion during the quarter, compared to the consensus estimate of $10.17 billion. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.94 EPS. sell-side analysts forecast that Cigna Corporation will post 10.34 EPS for the current year.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.